Cargando…
Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is a potentially devastating myopathy caused by de-repression of the DUX4 gene in skeletal muscles. Effective therapies will likely involve DUX4 inhibition. RNA interference (RNAi) is one powerful approach to inhibit DUX4, and we previously described a R...
Autores principales: | Saad, Nizar Y., Al-Kharsan, Mustafa, Garwick-Coppens, Sara E., Chermahini, Gholamhossein Amini, Harper, Madison A., Palo, Andrew, Boudreau, Ryan L., Harper, Scott Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654987/ https://www.ncbi.nlm.nih.gov/pubmed/34880230 http://dx.doi.org/10.1038/s41467-021-27430-1 |
Ejemplares similares
-
DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy
por: Lim, Kenji Rowel Q., et al.
Publicado: (2020) -
Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments
por: Duranti, Elisa, et al.
Publicado: (2023) -
Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models
por: Nunes, Andreia M., et al.
Publicado: (2021) -
RNAscope in situ hybridization-based method for detecting DUX4 RNA expression in vitro
por: Amini Chermahini, Gholamhossein, et al.
Publicado: (2019) -
Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics
por: Chen, Jennifer CJ, et al.
Publicado: (2016)